Excision repair cross-complementation group 1 (ERCC1) (the DNA repair gene) is a gene associated with platinum sensitivity and has been proposed as a novel biomarker of cervical cancer over the years (11, 12). This evidence concerns the gene ERCC1 and cervical carcinoma.